Literature DB >> 29600895

Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding.

Alan J Mouton1, Osvaldo J Rivera1, Merry L Lindsey1,2.   

Abstract

After myocardial infarction, remodeling of the left ventricle involves a wound-healing orchestra involving a variety of cell types. In order for wound healing to be optimal, appropriate communication must occur; these cells all need to come in at the right time, be activated at the right time in the right amount, and know when to exit at the right time. When this occurs, a new homeostasis is obtained within the infarct, such that infarct scar size and quality are sufficient to maintain left ventricular size and shape. The ideal scenario does not always occur in reality. Often, miscommunication can occur between infarct and remote spaces, across the temporal wound-healing spectrum, and across organs. When miscommunication occurs, adverse remodeling can progress to heart failure. This review discusses current knowledge gaps and recent development of the roles of inflammation and the extracellular matrix in myocardial infarction remodeling. In particular, the macrophage is one cell type that provides direct and indirect regulation of both the inflammatory and scar-forming responses. We summarize current research efforts focused on identifying biomarker indicators that reflect the status of each component of the wound-healing process to better predict outcomes.

Entities:  

Keywords:  extracellular matrix; fibroblast; inflammation; macrophage; proteomics; scar; systems biology

Mesh:

Year:  2018        PMID: 29600895      PMCID: PMC6087773          DOI: 10.1152/ajpheart.00131.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  129 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

2.  Neutrophil contributions to ischaemic heart disease.

Authors:  Friedrich Felix Hoyer; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2017-02-14       Impact factor: 29.983

3.  Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Nicolle L Patterson; Manishabrata Bhowmick; Elizabeth R Flynn; Majdouline Asher; Presley L Cannon; Kristine Y Deleon-Pennell; Gregg B Fields; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2016-10-13       Impact factor: 5.000

Review 4.  Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps.

Authors:  Yonggang Ma; Rugmani Padmanabhan Iyer; Mira Jung; Michael P Czubryt; Merry L Lindsey
Journal:  Trends Pharmacol Sci       Date:  2017-03-29       Impact factor: 14.819

5.  Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Authors:  Hiroe Toba; Presley L Cannon; Andriy Yabluchanskiy; Rugmani Padmanabhan Iyer; Jeanine D'Armiento; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

6.  Crossing Into the Next Frontier of Cardiac Extracellular Matrix Research.

Authors:  Francis G Spinale; Nikolaos G Frangogiannis; Boris Hinz; Jeffrey W Holmes; Zamaneh Kassiri; Merry L Lindsey
Journal:  Circ Res       Date:  2016-10-28       Impact factor: 17.367

7.  Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction.

Authors:  Elizabeth F Lopez; Janusz H Kabarowski; Kevin A Ingle; Vasundhara Kain; Stephen Barnes; David K Crossman; Merry L Lindsey; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

8.  In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing.

Authors:  Gabriel Courties; Timo Heidt; Matthew Sebas; Yoshiko Iwamoto; Derrick Jeon; Jessica Truelove; Benoit Tricot; Greg Wojtkiewicz; Partha Dutta; Hendrik B Sager; Anna Borodovsky; Tatiana Novobrantseva; Boris Klebanov; Kevin Fitzgerald; Daniel G Anderson; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Am Coll Cardiol       Date:  2013-12-18       Impact factor: 24.094

Review 9.  Monocyte and macrophage contributions to cardiac remodeling.

Authors:  Maarten Hulsmans; Flora Sam; Matthias Nahrendorf
Journal:  J Mol Cell Cardiol       Date:  2015-11-21       Impact factor: 5.000

10.  TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.

Authors:  Hai Tian; Massimo Cimini; Paul W M Fedak; Svetlana Altamentova; Shafie Fazel; Ming-Li Huang; Richard D Weisel; Ren-Ke Li
Journal:  J Mol Cell Cardiol       Date:  2007-09-14       Impact factor: 5.000

View more
  22 in total

Review 1.  Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction.

Authors:  Alan J Mouton; Osvaldo J Rivera Gonzalez; Amanda R Kaminski; Edwin T Moore; Merry L Lindsey
Journal:  Pharmacol Res       Date:  2018-10-28       Impact factor: 7.658

Review 2.  Extracellular matrix in cardiovascular pathophysiology.

Authors:  Maria Bloksgaard; Merry Lindsey; Luis A Martinez-Lemus
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-21       Impact factor: 4.733

3.  Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction.

Authors:  Merry L Lindsey; Yonggang Ma; Elizabeth R Flynn; Michael D Winniford; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-20       Impact factor: 5.187

4.  Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators.

Authors:  Weiang Yan; Ejlal Abu-El-Rub; Sekaran Saravanan; Lorrie A Kirshenbaum; Rakesh C Arora; Sanjiv Dhingra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

5.  Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Ruicong Guan; Kuan Zeng; Bin Zhang; Minnan Gao; Jianfen Li; Huiqi Jiang; Yuqiang Liu; Yongjia Qiang; Zhuxuan Liu; Jingwen Li; Yanqi Yang
Journal:  Front Cardiovasc Med       Date:  2022-06-15

6.  Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.

Authors:  Jianrui Song; Ryan A Frieler; Steven E Whitesall; Yutein Chung; Thomas M Vigil; Lindsey A Muir; Jun Ma; Frank Brombacher; Sascha N Goonewardena; Carey N Lumeng; Daniel R Goldstein; Richard M Mortensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-08       Impact factor: 4.733

7.  CircRNA 010567 plays a significant role in myocardial infarction via the regulation of the miRNA-141/DAPK1 axis.

Authors:  Qinge Zhao; Weichao Li; Wei Pan; Ziyao Wang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

8.  Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.

Authors:  Alan J Mouton; Elizabeth R Flynn; Sydney P Moak; Nikaela M Aitken; Ana C M Omoto; Xuan Li; Alexandre A da Silva; Zhen Wang; Jussara M do Carmo; John E Hall
Journal:  J Mol Cell Cardiol       Date:  2021-05-21       Impact factor: 5.763

9.  Temporal Changes in Pollen Concentration Predict Short-Term Clinical Outcomes in Acute Coronary Syndromes.

Authors:  Omar Al-Mukhtar; Sara Vogrin; Edwin R Lampugnani; Samer Noaman; Diem T Dinh; Angela L Brennan; Christopher Reid; Jeffrey Lefkovits; Nicholas Cox; Dion Stub; William Chan
Journal:  J Am Heart Assoc       Date:  2022-03-15       Impact factor: 6.106

Review 10.  Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.

Authors:  Filippos Triposkiadis; Andrew Xanthopoulos; John Parissis; Javed Butler; Dimitrios Farmakis
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.